HIMT 2011 launched
A mega International event on Healthcare Infrastructure and Medical Technology
A mega International event on Healthcare Infrastructure and Medical Technology
A newly developed optical touch pointer can be used to differentiate healthy tissues from tumours and help surgeons during the resection of malignant brain tumours, a study published in the journal Lasers in Surgeryhas reported.
A wearable artificial pancreas could control type 1 diabetes during pregnancy, according to a study conducted by researchers at Cambridge University in the UK.
Contrast-enhanced ultrasound can safely improve the diagnosis of a variety of medical conditions in children, according to a study by researchers at Jena University Hospital, Germany.
Onset of epilepsy during childhood triples the long term mortality risk, suggests a recently published study in a medical journal.
A new medical imager with the potential to spot ultra small breast tumors have been developed by the research teams of the West Virginia University School of Medicine and the Maryland School of Medicine. The imager is adept in not only detecting tumors but also in guiding the biopsy of suspicious-looking breast cancer lesions.
A new technology has been tested for the first time on people which can give a 3-D image of the patient’s arteries and better treat heart diseases.
Royal Philips Electronics recently announced that it is leading a major new European project to develop drug delivery technologies that could significantly impact the treatment of cancer and cardiovascular disease.
Australian researchers are developing new antibodies which will speeden up the healing of burns and chronic ulcers and benefit diabetes patients.
The Ignite Institute for Individualized Health, a new medical research startup has acquired a new gene sequencing machine.
The UAE has launched a nationwide immunisation programme to protect infants from six diseases.
The Methodist DeBakey Heart & Vascular Center is chosen as a site for a critical percutaneous heart valve study.
A new type of molecular imaging procedure may be capable of detecting the presence of beta-amyloid, a protein linked to Alzheimer’s disease.